This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oaktree Fund Administration, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Richard Lin
Introduction
Richard Lin is a notable inventor based in New York, NY (US). He has made significant strides in the field of cancer treatment through his innovative research and development. His work primarily focuses on the use of mesenchymal lineage precursor cells or stem cells for the delivery of oligonucleotides in cancer therapy.
Latest Patents
Richard Lin holds a patent for the "Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer." This patent highlights his commitment to advancing medical science and improving treatment options for cancer patients. He has 1 patent to his name, showcasing his contributions to the field.
Career Highlights
Richard Lin is currently employed at Oaktree Fund Administration, LLC, where he continues to apply his expertise in innovative solutions. His role at the company allows him to collaborate with other professionals in the industry and contribute to groundbreaking research.
Collaborations
Richard has worked alongside notable colleagues such as Ira Cohen and Nick Loizos. Their combined efforts in research and development have furthered advancements in their respective fields.
Conclusion
Richard Lin's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in medical technology and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile